The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial

• Main Authors: van Tilborg Theodora C (Author), Eijkemans Marinus JC (Author), Laven Joop SE (Author), Koks Carolien AM (Author), de Bruin Jan (Author), Scheffer Gabrielle J (Author), van Golde Ron JT (Author), Fleischer Kathrin (Author), Hoek Annemieke (Author), Nap Annemiek W (Author), Kuchenbecker Walter KH (Author), Manger Petra A (Author), Brinkhuis Egbert A (Author), van Heusden Arne M (Author), Sluijmer Alexander V (Author), Verhoeff Arie (Author), van Hooff Marcel HA (Author), Friederich Jaap (Author), Smeenk Jesper MJ (Author), Kwee Janet (Author), Verhoeve Harold R (Author), Lambalk Cornelis B (Author), Helmerhorst Frans M (Author), van der Veen Fulco (Author), Mol Ben Willem J (Author), Torrance Helen L (Author), Broekmans Frank JM (Author)
• Format: Book
• Published: BMC, 2012-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Costs of in vitro fertilisation (IVF) are high, which is partly due to the use of follicle stimulating hormone (FSH). FSH is usually administered in a standard dose. However, due to differences in ovarian reserve between women, ovari...